Home Cart 0 Sign in  

[ CAS No. 154127-42-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 154127-42-1
Chemical Structure| 154127-42-1
Structure of 154127-42-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 154127-42-1 ]

Related Doc. of [ 154127-42-1 ]

Alternatived Products of [ 154127-42-1 ]

Product Details of [ 154127-42-1 ]

CAS No. :154127-42-1 MDL No. :MFCD09033313
Formula : C10H16N2O6S3 Boiling Point : -
Linear Structure Formula :- InChI Key :UHIWBQIWXWWDKT-MRVPVSSYSA-N
M.W : 356.44 Pubchem ID :15225314
Synonyms :

Calculated chemistry of [ 154127-42-1 ]

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.6
Num. rotatable bonds : 5
Num. H-bond acceptors : 8.0
Num. H-bond donors : 2.0
Molar Refractivity : 79.55
TPSA : 172.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.11 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.61
Log Po/w (XLOGP3) : -0.89
Log Po/w (WLOGP) : 0.93
Log Po/w (MLOGP) : -1.93
Log Po/w (SILICOS-IT) : -0.47
Consensus Log Po/w : -0.35

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.34
Solubility : 16.5 mg/ml ; 0.0462 mol/l
Class : Very soluble
Log S (Ali) : -2.24
Solubility : 2.05 mg/ml ; 0.00576 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.54
Solubility : 10.3 mg/ml ; 0.0289 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.12

Safety of [ 154127-42-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 154127-42-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 154127-42-1 ]
  • Downstream synthetic route of [ 154127-42-1 ]

[ 154127-42-1 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 1245550-91-7 ]
  • [ 154127-42-1 ]
YieldReaction ConditionsOperation in experiment
65.2%
Stage #1: With (-)-chlorodiisopinocampheylborane In hexane; tert-butyl methyl ether at -40 - -20℃; Inert atmosphere
Stage #2: With sodium hydroxide In hexane; tert-butyl methyl ether; water at 25 - 30℃;
The cyclisation of compound (Vl) may be carried out using a chiral reducing agent such as (+)-diisopinocamphenylborane (DIPCI) in order to obtain the desired isomer of compound (VII) by a stereoselective reduction. Compound (Vl) (21Og, 0.484 moles) was suspended in t-butyl methyl ether (15 vol) and stirred under nitrogen atmosphere. The stirred suspension was cooled to -400C and (+)-diisopinocamphenylborane (DIPCI) (762g (60-65percent in hexane solution), 1.063 moles) was added via a cannula over a period of 30 minutes. A rise in temperature (upto -300C) was observed. The reaction mixture was maintained at -25 to -2O0C for 3.0 to 4.0 h and monitored by TLC [mobile phase ethyl acetate: hexane, 3:7].After completion of the reduction, 1 M aqueous sodium hydroxide solution (20 vol) was added from an addition funnel over a period of 15-20 minutes, The reaction mixture was stirred at 25-30°C overnight and monitored by TLC[Mobile phase Ethyl acetate: hexane, 1 :1] for completion. After completion, the aqueous and organic phases were separated and the aqueous phase was extracted with t-butyl methyl ether (4.0 vol), acidified to pH 1 using 5N hydrochloric acid solution and extracted with ethyl acetate (3 x 6.0 vol). The combined ethyl acetate extracts were washed with saturated brine solution(2 x 2.5 vol), dried over sodium sulphate and filtered. The organic layer was distilled completely (below 500C) under reduced pressure. The crude product obtained was a pale yellow colored syrup.Yield of compound (VIl): 112 g (65.2percent)Alternatively, step (f) may also be carried out using a non-chiral reducing agent such as sodium tetrahydroborane. In this case, subsequent optical resolution steps, i.e. removal of undesired isomer, have to be carried out.
Reference: [1] Patent: WO2010/103115, 2010, A1, . Location in patent: Page/Page column 15-16
  • 2
  • [ 1029324-91-1 ]
  • [ 154127-42-1 ]
YieldReaction ConditionsOperation in experiment
60%
Stage #1: With sec.-butyllithium In tetrahydrofuran; cyclohexane at -5 - 0℃; for 8.75 h; Inert atmosphere
Stage #2: With sulfur dioxide In tetrahydrofuran; cyclohexane at -65 - 20℃; Inert atmosphere
Stage #3: With sodium acetate trihydrate; hydroxylamine-O-sulfonic acid In water at 0 - 20℃;
Method 2
3,4-Dihydro-4(S)-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide (IX)
A solution of the compound from step F (58 g, 0.21 moles) in tetrahydrofuran (1000 ml) was cooled to -5 to 0° C. under nitrogen atmosphere. Sec-butyl lithium (464 ml of 1.4 M solution in cyclohexane) was added to the above solution over 45 min while maintaining the temperature at -5 to 0° C.
The mixture was stirred for 8 hours at the temperature less than 0° C. and cooled to -65° C. and sulfur dioxide gas was bubbled through reaction mass at -65° C. till the reaction mixture is acidic.
The reaction mixture was stirred overnight while warming it to ambient temperature.
The reaction mixture was concentrated to dryness on rotary evaporator to get the lithium sulfinate salt, which was further dissolved in cold water (1160 ml) and washed with ethyl acetate (580 ml).
Sodium acetate trihydrate (142.8 g, 1.05 moles) was added and the solution was cooled to 0 to 5° C. Hydroxylamine-O-sulfonic acid (101 g, 0.89 mol) was added slowly to reaction mass below 5° C.
The reaction mass was stirred at ambient temperature overnight.
The reaction mixture was extracted with ethyl acetate (2*1200 ml)) and the combined extracts were washed with sodium carbonate solution, brine and dried over sodium sulfate.
Evaporation to dryness gave a viscous oily compound which was further stirred with dichloromethane (250 ml) to get solid.
The product was isolated by filtration.
The product was further washed with Dichloromethane, dried in air to yield compound of the formula compound IX (45 g, 60percent).
Reference: [1] Patent: US2010/9977, 2010, A1, . Location in patent: Page/Page column 11
  • 3
  • [ 160982-13-8 ]
  • [ 154127-42-1 ]
Reference: [1] Organic Process Research and Development, 1999, vol. 3, # 2, p. 114 - 120
  • 4
  • [ 154127-41-0 ]
  • [ 111-42-2 ]
  • [ 154127-42-1 ]
Reference: [1] Patent: US5378703, 1995, A,
  • 5
  • [ 36157-40-1 ]
  • [ 154127-42-1 ]
Reference: [1] Organic Process Research and Development, 1999, vol. 3, # 2, p. 114 - 120
  • 6
  • [ 160982-09-2 ]
  • [ 154127-42-1 ]
Reference: [1] Organic Process Research and Development, 1999, vol. 3, # 2, p. 114 - 120
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 154127-42-1 ]

Ethers

Chemical Structure| 154127-41-0

[ 154127-41-0 ]

2-(3-Methoxypropyl)-4-oxo-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide

Similarity: 0.80

Chemical Structure| 1025424-03-6

[ 1025424-03-6 ]

4-Methoxy-2-tosylisoindoline

Similarity: 0.50

Alcohols

Chemical Structure| 160982-16-1

[ 160982-16-1 ]

(S)-6-Chloro-4-hydroxy-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine 1,1-dioxide

Similarity: 0.76

Chemical Structure| 1349199-60-5

[ 1349199-60-5 ]

3-Ethynyl-1-tosylazetidin-3-ol

Similarity: 0.50

Amines

Chemical Structure| 154127-41-0

[ 154127-41-0 ]

2-(3-Methoxypropyl)-4-oxo-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide

Similarity: 0.80

Chemical Structure| 100342-30-1

[ 100342-30-1 ]

N-tert-Butyl-2-thiophenesulfonamide

Similarity: 0.62

Chemical Structure| 286932-39-6

[ 286932-39-6 ]

N-tert-Butyl 5-bromo-2-thiophenesulfonamide

Similarity: 0.57

Chemical Structure| 155731-14-9

[ 155731-14-9 ]

5-Chlorothiophene-2-sulfonic acid tert-butylamide

Similarity: 0.56

Chemical Structure| 203640-27-1

[ 203640-27-1 ]

(R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid

Similarity: 0.52

Sulfamides

Chemical Structure| 154127-41-0

[ 154127-41-0 ]

2-(3-Methoxypropyl)-4-oxo-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide

Similarity: 0.80

Chemical Structure| 160982-16-1

[ 160982-16-1 ]

(S)-6-Chloro-4-hydroxy-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine 1,1-dioxide

Similarity: 0.76

Chemical Structure| 100342-30-1

[ 100342-30-1 ]

N-tert-Butyl-2-thiophenesulfonamide

Similarity: 0.62

Chemical Structure| 286932-39-6

[ 286932-39-6 ]

N-tert-Butyl 5-bromo-2-thiophenesulfonamide

Similarity: 0.57

Chemical Structure| 155731-14-9

[ 155731-14-9 ]

5-Chlorothiophene-2-sulfonic acid tert-butylamide

Similarity: 0.56

Related Parent Nucleus of
[ 154127-42-1 ]

Other Aromatic Heterocycles

Chemical Structure| 154127-41-0

[ 154127-41-0 ]

2-(3-Methoxypropyl)-4-oxo-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide

Similarity: 0.80

Chemical Structure| 160982-16-1

[ 160982-16-1 ]

(S)-6-Chloro-4-hydroxy-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine 1,1-dioxide

Similarity: 0.76